Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Montaner

Showing results (1-10 of 189) with videos related to

Pageof 19
Sort By:
JAMA|May 18, 1999
Induction/maintenance treatment regimens for HIVJ S Montaner
Reviews in Medical Virology|July 13, 2000
Clinical uses of non-nucleoside reverse transcriptase inhibitorsM Harris, J S Montaner
Lancet (London, England)|February 11, 1995
Cautious optimism over new anti-HIV agentsJ S Montaner, M O'Shaughnessy
Lancet (London, England)|December 23, 1995
A year of transformation in HIV/AIDSJ S Montaner, M T Schechter
The New England Journal of Medicine|August 11, 2001
Antiretroviral therapy for previously treated patientsJ S Montaner, J W Mellors
AIDS (London, England)|February 1, 1995
Octreotide therapy in AIDS-related, refractory diarrhea: results of a multicentre Canadian-European study. Octreotide International Multicentre AIDS-Diarrhea StudyJ S Montaner, A G Harris
Lancet (London, England)|August 20, 1994
Time for realism over HIV infectionJ S Montaner, M T Schechter
Journal of Biological Regulators and Homeostatic Agents|July 1, 1995
A clinician's perspective: when to start antiretroviral treatment and when to change therapyJ S Montaner, J M Lange
Antiviral Therapy|February 22, 2000
Effective salvage therapy for HIV-1 infection--an unmet challengeJ S Montaner, J W Mellors
Annals of Internal Medicine|May 15, 1990
Zidovudine for early human immunodeficiency virus (HIV) infection: who, when, and how?J Ruedy, M Schechter, J S Montaner
Pageof 19

Showing results (1-10 of 189) with videos related to

Sort By:
Pageof 19
JAMA|May 18, 1999
Induction/maintenance treatment regimens for HIVJ S Montaner
Reviews in Medical Virology|July 13, 2000
Clinical uses of non-nucleoside reverse transcriptase inhibitorsM Harris, J S Montaner
Lancet (London, England)|February 11, 1995
Cautious optimism over new anti-HIV agentsJ S Montaner, M O'Shaughnessy
Lancet (London, England)|December 23, 1995
A year of transformation in HIV/AIDSJ S Montaner, M T Schechter
The New England Journal of Medicine|August 11, 2001
Antiretroviral therapy for previously treated patientsJ S Montaner, J W Mellors
AIDS (London, England)|February 1, 1995
Octreotide therapy in AIDS-related, refractory diarrhea: results of a multicentre Canadian-European study. Octreotide International Multicentre AIDS-Diarrhea StudyJ S Montaner, A G Harris
Lancet (London, England)|August 20, 1994
Time for realism over HIV infectionJ S Montaner, M T Schechter
Journal of Biological Regulators and Homeostatic Agents|July 1, 1995
A clinician's perspective: when to start antiretroviral treatment and when to change therapyJ S Montaner, J M Lange
Antiviral Therapy|February 22, 2000
Effective salvage therapy for HIV-1 infection--an unmet challengeJ S Montaner, J W Mellors
Annals of Internal Medicine|May 15, 1990
Zidovudine for early human immunodeficiency virus (HIV) infection: who, when, and how?J Ruedy, M Schechter, J S Montaner
Pageof 19